HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?

Abstract
The ganglioside composition of the brain from an individual with classical Tay-Sachs disease and from an individual with Sandhoff disease was examined using our new quantitative methods for ganglioside content determination and compared with that of age-matched control brains. The concentration of GM2 was found to be 12.2 and 13.0 mumol/g of fresh tissue in Tay-Sachs disease and in Sandhoff disease cerebral gray matter, respectively. GM2 was 86 and 87% respectively, of total gangliosides. The concentration of GM1 and, in particular, GM3 ganglioside was also found to be increased, whereas the concentration of the major di- and trisialogangliosides (GD1a, GD1b, and GT1b) had diminished markedly. There was no significant increase in level of any other ganglioside than lyso-GM2. Its concentration was 12 and 16 nmol/g in cerebral gray matter of two Tay-Sachs disease brains and 43 nmol/g in Sandhoff disease brain. The Sandhoff disease brain also differed from the classical Tay-Sachs disease brain by having a much higher concentration of gangliotriaosylceramide and globotetraosylceramide. The structures of relevant gangliosides and neutral glycolipids were established by fast atom bombardment-mass spectrometry and permethylation studies.
AuthorsB Rosengren, J E Månsson, L Svennerholm
JournalJournal of neurochemistry (J Neurochem) Vol. 49 Issue 3 Pg. 834-40 (Sep 1987) ISSN: 0022-3042 [Print] England
PMID3612128 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Gangliosides
  • Glycosphingolipids
  • Lactosylceramides
  • lysoganglioside G(M2)
  • G(M2) Ganglioside
  • lactotriaosylceramide
Topics
  • Brain Chemistry
  • Child, Preschool
  • Chromatography, Thin Layer
  • Female
  • Fetus (analysis)
  • G(M2) Ganglioside (analogs & derivatives, analysis)
  • Gangliosides (analysis)
  • Glycosphingolipids (analysis)
  • Humans
  • Lactosylceramides (analysis)
  • Male
  • Mass Spectrometry
  • Sandhoff Disease (metabolism)
  • Tay-Sachs Disease (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: